SCICONX Journal of Advances in Diabetes Biology

The SCICONX Journal of Advances in Diabetes Biology (JADB) is a peer-reviewed, international, open-access scientific journal dedicated to advancing our understanding of the biological foundations of diabetes and metabolic disorders. JADB serves as a premier platform for cutting-edge research that deepens insights into mechanisms, pathways, biomarkers, and translational science shaping the future of diabetes biology.

At JADB, we believe that groundbreaking discoveries in molecular, cellular, and systems biology will pave the way for next-generation diagnoses, prevention strategies, and therapeutic innovations for diabetes - one of the most pressing global health challenges of the 21st century.

✦ Our Vision

To be the leading journal for high-quality research that elucidates the biological drivers of diabetes, accelerates translational breakthroughs, and fosters interdisciplinary collaboration across the global scientific community.

✦ Scope of the Journal

JADB publishes innovative research and authoritative reviews across all areas of diabetes biology, including but not limited to:

• Molecular & Cellular Mechanisms
• Insulin synthesis and secretion biology
• Beta-cell function, survival, and regeneration
• Signalling pathways in glucose homeostasis
• Metabolic Regulation & Endocrine Crosstalk
• Insulin resistance and metabolic stress pathways
• Lipid metabolism and glucotoxicity
• Interplay between adipose, muscle, and hepatic tissues
• Immunometabolism & Chronic Inflammation
• Autoimmune triggers in type 1 diabetes
• Immune modulation in type 2 diabetes
• Cytokines, chemokines, and inflammatory networks
• Genomics, Epigenetics & Precision Biology
• Gene-environment interactions
• Epigenomic modulation in metabolic dysfunction
• Functional genomics and diabetes susceptibility
• Systems Biology & Microbiome Interactions
• Gut-microbiota influence on metabolic health
• Host-microbe signalling and metabolomics
• Integrated systems-level network biology
• Emerging Technologies & Translational Models
• CRISPR, organoids, and advanced in vitro modelling
• Computational biology and metabolic network simulation
• Biomarker discovery and early-stage therapeutic targets

✦ Why Publish with JADB?

Rigorous & Transparent Peer Review

All manuscripts undergo comprehensive evaluation by experts in diabetes biology, ensuring scientific integrity and high editorial standards.

✦ Open Access - Maximizing Global Impact

JADB is committed to open access. All accepted articles are freely accessible to researchers, clinicians, and policymakers worldwide, fostering greater visibility and citation potential.

✦ Expedited Publication Pathways

Strategic editorial processes support timely assessments and rapid publication, without compromising quality.

✦ International Editorial Expertise

Our editorial board comprises leading scientists and clinicians from top research institutions around the world - bringing diverse perspectives and clinical relevance to the journal.

✦ Types of Articles We Publish

JADB accepts a range of scholarly contributions, including:

• Original Research Articles
• Comprehensive Review Articles
• Short Communications
• Perspectives & Opinion Pieces
• Case Reports with Biological Insights
• Methodological Advances in Diabetes Biology

✦ Ethics, Integrity & Standards

The journal adheres to the highest ethical principles in research and publishing. All submissions must comply with ethical guidelines for human and animal studies, data transparency, and reproducibility. Plagiarism detection, conflict of interest disclosures, and ethical compliance checks are integral to our review process.

✦ Indexing & Archiving

JADB is committed to rapid eligibility for key indexing databases to enhance article discoverability and academic influence. We pursue indexing in recognized scholarly repositories and support long-term archiving for enduring access to published research.

✦ Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of € 99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.

✦ Who Should Read JADB?

✨ Our audience includes researchers, clinicians, educators, and graduate students specializing in:

✨ Molecular biology of metabolic diseases

✨ Endocrinology and physiology

✨ Systems biology and omics science

✨ Immunology and inflammation research

✨ Biomedical engineering and computational biology

✨ Translational and clinical research

✦ Join Our Community

Become part of a growing community of scientists dedicated to unravelling the complexities of diabetes biology. Whether you are submitting your research, serving as a reviewer, or staying informed on emerging discoveries, JADB offers a home for world-class scientific communication.

➡️ Submit Your Manuscript Today - Advance science. Transform care.